
Industry experts highlight the gut-ovary connection as an untapped market opportunity and the potential of traditional botanicals in women's wellness.

Industry experts highlight the gut-ovary connection as an untapped market opportunity and the potential of traditional botanicals in women's wellness.

Symrise and Probi expanded formulation horizons at Vitafoods Europe, launching stable postbiotics and clinical botanicals for active nutrition and wellness.

In this preview of the upcoming The Outlook on Women's Wellness, Gene Bruno, DBM, MS, RH(AHG), Chief Scientific Officer with Nutraland USA, discusses why effective bone health formulations must evolve beyond traditional ingredients, prioritizing life-stage-specific support and the critical need for more clinical research on women.

Arla Foods Ingredients introduced high-protein food and beverage concepts at Vitafoods Europe, targeting the fast-growing GLP-1 companion weight-management market.

In this preview of the upcoming The Outlook on Women's Wellness, Stacey Smith, DC, Senior Medical Science Liaison at Gnosis by Lesaffre, shares insights into product development for women's health solutions.

The 90% TG Premium fish oil with 900 mg/g EPA/DHA enables high-potency supplement formulations with smaller capsule sizes while maintaining sensory profiles.

The recognition for Ashwa.30 at the Barcelona show highlights a broader industry interest in clinically studied, low-dose botanical ingredients targeting sports nutrition, stress support, and active lifestyle formulations.

The ingredient supplier is advancing a broader longevity platform centered on pairing mechanistic aging science with clinically measurable benefits in mobility, cognition, and performance.

With a positive EFSA opinion in hand, Nutriearth highlights a bioactive vitamin D3 oil and functional powder designed for improved absorption, lower dosing, and sustainable fortification strategies at Vitafoods Europe.

In this preview of the upcoming The Outlook on Women's Wellness, Ayla Barmmer, MS, RD, LDN, Founder and CEO of FullWell, discusses new models of ovary health and new perspectives on women's health support.

In this preview of the upcoming The Outlook on Women's Wellness, Jennifer Greer, ND, MEd, Scientific Advisor/Medical Affairs Consultant, discusses significant opportunities for innovation for menopause management using traditional botanicals.

Following SupplySide Connect New Jersey, Rafal Pietruszynski, CEO of Greenvit, outlines how shifting aronia’s focus to gut and metabolic health, paired with supply stability, proprietary extraction, and strategic partnerships, could unlock new opportunities for Aronvit in the functional ingredient market.

Pharmactive announces launch of Kyoh, a hair health supplement that is an extract of Eruca sativa leaf (rocket leaves).

New delivery system for Morikol marine collagen tripeptide reflects ongoing innovation in beauty-from-within formats, emphasizing convenience, bioavailability, and low-dose efficacy.

BGG will showcase three of its clinically studied ingredients—ApplePhenon, TheraPrimE, and AstaZine— highlighting human research supporting benefits and holistic wellness.

At SupplySide Connect New Jersey, Chief Science Officer Catherine Kwik-Uribe explains how Cryopure technology, real-world data, and targeted ingredients are reshaping functional beverages and consumer outcomes.

At Vitafoods Europe, Concordix will showcase new chewable supplement concepts leveraging its patented emulsion platform, designed to address bioavailability, formulation complexity, and consumer experience.

Live from SupplySide Connect, Megan Olsen, the SVP and general counsel for the CRN, discusses the FDA public meeting on dietary ingredients, the NDI vs. GRAS pathway, and the need for a clear, modern regulatory scope.

Jennifer Chase, director of business development for Saanroo, sat down with Nutritional Outlook at SupplySide Connect NJ to highlight the findings of recently published research demonstrating the metabolic health benefits of its Trpti OEA.

At SupplySide Connect New Jersey, BioVivo highlights green tea and green coffee-derived caffeine as a cleaner alternative to synthetic sources, offering smoother energy and stronger appeal in functional beverages.

Live from SupplySide Connect, Megan Olsen, the SVP and general counsel for the CRN highlights growing concerns around DSHEA’s drug preclusion provision, underscoring the need for industry alignment and legislative reform in order to enable industry innovation.

At SupplySide Connect New Jersey, Megan Olsen, SVP and general counsel of CRN, explains the organization's recent petition to the US Supreme Court to review a recent New York State law regarding supplements violates free speech.

At SupplySide Connect New Jersey, Jim Roza explains how domestic partnerships, seed innovation, and close-to-source manufacturing are shaping more consistent, clinically relevant botanical extracts.

At SupplySide Connect New Jersey, Suresh Lakshmikanthan, PhD, Natural Remedies’ chief business officer, describes new findings on Ashwa-30 that highlight how measurable biomarkers can help practitioners tailor protocols for stress, fatigue, and physical strain.

The newly trademarked technologies will be showcased at Vitafoods Europe 2026, highlighting the platform’s dual-action effect on nutrient delivery.

At SupplySide Connect New Jersey, Suresh Lakshmikanthan, PhD, Natural Remedies’ chief business officer, explains how dual-standardized Ashwa-30 leverages ATP-active compounds and withanolides to deliver energy, endurance, and metabolic benefits at just 30 mg.

Nektium will showcase energy beverage concepts, featuring Zynamite RTDs and Rhodiolife-infused coffees at the event.

At a SupplySide Connect New Jersey session, industry experts unpack the trends reshaping product development, from protein dominance and fiber innovation, to sustainability, certifications, and shifting consumer trust.

At SupplySide Connect New Jersey, Keely Johnson, Arjuna Natural’s vice president of sales and marketing, discusses new clinical findings on Shoden ashwagandha, including its impact on stress, sleep, and cognitive performance in women ages 30–59.

A randomized controlled trial shows Zensera delivers same-day cognitive benefits and supports emotional balance under stress.